- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Authors
Latest:
Impact of a Value-Based Formulary in Three Chronic Disease CohortsA value-based formulary was implemented that used cost-effectiveness analysis to inform medication co-payments. Diabetes cohort expenditures decreased by $9 per member per month.
Latest:
US Prevalence of Upper Gastrointestinal Symptoms: A Systematic Literature ReviewSystematic review and meta-analysis suggest that upper gastrointestinal symptoms and disorders are common to inhabitants of the United States.
Latest:
Predicting Opioid Use Disorder and Associated Risk Factors in a Medicaid Managed Care PopulationA Medicaid managed care organization developed a machine learning model to identify opioid use disorder (OUD) risk factors and predict OUD incidence in its multistate population.
Latest:
Higher 30-Day and 60-Day Readmissions Among Patients Who Refuse Post Acute Care ServicesAlthough patients who refuse post acute care services are relatively young, well educated, and healthy, they are twice as likely to have 30- and 60-day readmissions compared with acceptors of services.
Latest:
Excess Hospitalization Days in an Academic Medical Center: Perceptions of Hospitalists and Discharge PlannersWe assessed the frequency of and reasons for medically unnecessary hospital days, which affect patients, payers, hospitals, and healthcare providers.
Latest:
Physician Variation in Lung Cancer Treatment at the End of LifePatients receiving care for advanced non—small cell lung cancer in small, independent oncology practices are more likely to receive chemotherapy in the last 30 days of life.
Latest:
Impact of Hospital-Physician Integration on Medicare Patient MixThis study found no evidence that hospital employment of physicians resulted in physicians treating sicker patients, undercutting claims that hospital-employed physicians serve a higher-acuity patient mix.
Latest:
Limited Distribution Networks Stifle Competition in the Generic and Biosimilar Drug IndustriesA limited distribution network is a pharmaceutical distribution strategy that some drug companies have capitalized upon to obstruct generic and biosimilar competition.
Latest:
Measuring Patient-Centered Medical Home Access and Continuity in Clinics With Part-Time CliniciansCommonly used measures of performance for assessing patient access do not reflect PCMH-encouraged strategies to improve access that may be preferentially used by part-time physicians.
Latest:
Improving Partnerships Between Health Plans and Medical GroupsTo provide guidance for successful partnerships, the authors identify common themes from their experience with successful health plan/medical group partnerships programs.
Latest:
Health Information Technology and Physicians' Knowledge of Drug CostsHigh rates of health information technology use by physicians were only modestly associated with better knowledge of drug costs.
Latest:
One Size Does Not Always Fit All in Value AssessmentLaying a clear path for incorporating reliable evidence on heterogeneity in value assessments could improve their applicability for healthcare decision making.
Latest:
Postacute Care Partnerships and Patient ProgressionPostacute care partners are required for successful patient transitions. Collaboration among multidisciplinary teams and community resources is critical for discharge planning and partnership alignment.
Latest:
Against the Current: Back-Transfer as a Mechanism for Rural RegionalizationThe authors investigated back-transfer: the transfer of patients near the end of an acute hospitalization to a local community hospital for completion of their medical care.
Latest:
Treatment of Diabetes Mellitus: The Urgent Need for Multifactorial InterventionsThe pandemic of type 2 diabetes mellitus requires implementation of multifactorial interventions by clinicians for individual patients and policy makers for the health of the general public.
Latest:
Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung CancerThis review assesses the current molecular testing landscape for non–small-cell lung cancer in the United States.
Latest:
Guided Care and the Cost of Complex Healthcare: A Preliminary ReportThe early months of a cluster-randomized trial suggest that Guided Care is associated with a trend toward a net reduction in total healthcare expenditures.
Latest:
Increased Healthcare Utilization and Expenditures Associated With Chronic Opioid TherapyThe increase in healthcare utilization and expenditures associated with the transition to chronic opioid therapy places increased burden on payers and patients.
